A new study has identified a potential new target for treating triple-negative breast cancer, one of the most aggressive ...

New results from a clinical trial show that existing drugs can successfully kill dormant breast cancer cells, thereby reducing lifetime risk of recurrence.

Research reveals surprising risk factors and new hope for treatment Kampala, Uganda | PATRICIA AKANKWATSA | A five-year study ...

Thousands of survivors, health care professionals, and community organizers are rallying this Breast Cancer Awareness season ...

Risk factors for developing breast cancer include being female, increasing age, being overweight, alcohol consumption and ...

Frailty is associated with higher odds of local and systemic postoperative complications among older women with nonmetastatic ...

NIH award of $2.25M funds preclinical studies that will advance Targefrin toward clinical trials for pancreatic cancer ...

More cancer patients will soon be able to enroll in a groundbreaking Phase 2 clinical trial of a therapeutic breast cancer ...

Multigene panel testing may be warranted in patients with multiple primary cancer diagnoses, according to researchers.

To fill this gap we—researchers from Wits University, Sydney Brenner Institute for Molecular Bioscience, and our ...

Recent studies reveal a sharp increase in breast cancer cases among women under 50 with urgent calls for early detection and lifestyle changes.

Today, the American Association for Cancer Research (AACR) released the 15th edition of its annual Cancer Progress Report. A cornerstone of the AACR’s educational and advocacy efforts, this ...